Cargando…
Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study
BACKGROUND: Methods for accurate quantification of lung fluid in heart failure (HF) are needed. Dynamic contrast‐enhanced (DCE)‐MRI may be an appropriate modality. PURPOSE: DCE‐MRI evaluation of fraction of fluid volume in the interstitial lung space (v ( e )) and vascular permeability (K (trans))....
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544235/ https://www.ncbi.nlm.nih.gov/pubmed/35343008 http://dx.doi.org/10.1002/jmri.28174 |
_version_ | 1784804553820995584 |
---|---|
author | Cheriyan, Joseph Roberts, Alexandra Roberts, Caleb Graves, Martin J. Patterson, Ilse Slough, Rhys A. Schroyer, Rosemary Fernando, Disala Kumar, Subramanya Lee, Sarah Parker, Geoffrey J.M. Sarov‐Blat, Lea McEniery, Carmel Middlemiss, Jessica Sprecher, Dennis Janiczek, Robert L. |
author_facet | Cheriyan, Joseph Roberts, Alexandra Roberts, Caleb Graves, Martin J. Patterson, Ilse Slough, Rhys A. Schroyer, Rosemary Fernando, Disala Kumar, Subramanya Lee, Sarah Parker, Geoffrey J.M. Sarov‐Blat, Lea McEniery, Carmel Middlemiss, Jessica Sprecher, Dennis Janiczek, Robert L. |
author_sort | Cheriyan, Joseph |
collection | PubMed |
description | BACKGROUND: Methods for accurate quantification of lung fluid in heart failure (HF) are needed. Dynamic contrast‐enhanced (DCE)‐MRI may be an appropriate modality. PURPOSE: DCE‐MRI evaluation of fraction of fluid volume in the interstitial lung space (v ( e )) and vascular permeability (K (trans)). STUDY TYPE: Prospective, single‐center method validation. POPULATION: Seventeen evaluable healthy volunteers (HVs), 12 participants with HF, and 3 with acute decompensated HF (ADHF). FIELD STRENGTH/SEQUENCE: T (1) mapping (spoiled gradient echo variable flip angle acquisition) followed by dynamic series (three‐dimensional spoiled gradient‐recalled echo acquisitions [constant echo time, repetition time, and flip angle at 1.5 T]). ASSESSMENT: Three whole‐chest scans were acquired: baseline (Session 1), 1‐week later (Session 2), following exercise (Session 3). Extended Tofts model quantified v ( e ) and K (trans) (voxel‐wise basis); total lung median measures were extracted and fitted via repeat measure analysis of variance (ANOVA) model. Patient tolerability of the scanning protocol was assessed. STATISTICAL TESTS: This was constructed as an experimental medicine study. Primary endpoints: K (trans) and v ( e ) at baseline (HV vs. HF), change in K (trans) and v ( e ) following exercise, and following lung congestion resolution (ADHF). K (trans) and v ( e ) were fitted separately using ANOVA. Secondary endpoint: repeatability, that is, within‐participant variability in v ( e ) and K (trans) between sessions (coefficient of variation estimated via mixed effects model). RESULTS: There was no significant difference in mean K (trans) between HF and HV (P ≤ 0.17): 0.2216 minutes(−1) and 0.2353 minutes(−1) (Session 1), 0.2044 minutes(−1) and 0.2567 minutes(−1) (Session 2), 0.1841 minutes(−1) and 0.2108 minutes(−1) (Session 3), respectively. v ( e ) was greater in the HF group (all scans, P ≤ 0.02). Results were repeatable between Sessions 1 and 2; mean values for HF and HV were 0.4946 and 0.3346 (Session 1), 0.4353 and 0.3205 (Session 2), respectively. There was minimal difference in K (trans) or v ( e ) between scans for participants with ADHF (small population precluded significance testing). Scanning was well tolerated. DATA CONCLUSION: While no differences were detected in K (trans), v ( e ) was greater in chronic HF patients vs. HV, augmented beyond plasma and intracellular volume. DCE‐MRI is a valuable diagnostic and physiologic tool to evaluate changes in fluid volume in the interstitial lung space associated with symptomatic HF. LEVEL OF EVIDENCE: 2 TECHNICAL EFFICACY STAGE: 2 |
format | Online Article Text |
id | pubmed-9544235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95442352022-10-14 Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study Cheriyan, Joseph Roberts, Alexandra Roberts, Caleb Graves, Martin J. Patterson, Ilse Slough, Rhys A. Schroyer, Rosemary Fernando, Disala Kumar, Subramanya Lee, Sarah Parker, Geoffrey J.M. Sarov‐Blat, Lea McEniery, Carmel Middlemiss, Jessica Sprecher, Dennis Janiczek, Robert L. J Magn Reson Imaging Research Articles BACKGROUND: Methods for accurate quantification of lung fluid in heart failure (HF) are needed. Dynamic contrast‐enhanced (DCE)‐MRI may be an appropriate modality. PURPOSE: DCE‐MRI evaluation of fraction of fluid volume in the interstitial lung space (v ( e )) and vascular permeability (K (trans)). STUDY TYPE: Prospective, single‐center method validation. POPULATION: Seventeen evaluable healthy volunteers (HVs), 12 participants with HF, and 3 with acute decompensated HF (ADHF). FIELD STRENGTH/SEQUENCE: T (1) mapping (spoiled gradient echo variable flip angle acquisition) followed by dynamic series (three‐dimensional spoiled gradient‐recalled echo acquisitions [constant echo time, repetition time, and flip angle at 1.5 T]). ASSESSMENT: Three whole‐chest scans were acquired: baseline (Session 1), 1‐week later (Session 2), following exercise (Session 3). Extended Tofts model quantified v ( e ) and K (trans) (voxel‐wise basis); total lung median measures were extracted and fitted via repeat measure analysis of variance (ANOVA) model. Patient tolerability of the scanning protocol was assessed. STATISTICAL TESTS: This was constructed as an experimental medicine study. Primary endpoints: K (trans) and v ( e ) at baseline (HV vs. HF), change in K (trans) and v ( e ) following exercise, and following lung congestion resolution (ADHF). K (trans) and v ( e ) were fitted separately using ANOVA. Secondary endpoint: repeatability, that is, within‐participant variability in v ( e ) and K (trans) between sessions (coefficient of variation estimated via mixed effects model). RESULTS: There was no significant difference in mean K (trans) between HF and HV (P ≤ 0.17): 0.2216 minutes(−1) and 0.2353 minutes(−1) (Session 1), 0.2044 minutes(−1) and 0.2567 minutes(−1) (Session 2), 0.1841 minutes(−1) and 0.2108 minutes(−1) (Session 3), respectively. v ( e ) was greater in the HF group (all scans, P ≤ 0.02). Results were repeatable between Sessions 1 and 2; mean values for HF and HV were 0.4946 and 0.3346 (Session 1), 0.4353 and 0.3205 (Session 2), respectively. There was minimal difference in K (trans) or v ( e ) between scans for participants with ADHF (small population precluded significance testing). Scanning was well tolerated. DATA CONCLUSION: While no differences were detected in K (trans), v ( e ) was greater in chronic HF patients vs. HV, augmented beyond plasma and intracellular volume. DCE‐MRI is a valuable diagnostic and physiologic tool to evaluate changes in fluid volume in the interstitial lung space associated with symptomatic HF. LEVEL OF EVIDENCE: 2 TECHNICAL EFFICACY STAGE: 2 John Wiley & Sons, Inc. 2022-03-27 2022-08 /pmc/articles/PMC9544235/ /pubmed/35343008 http://dx.doi.org/10.1002/jmri.28174 Text en © 2022 GlaxoSmithKline. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Cheriyan, Joseph Roberts, Alexandra Roberts, Caleb Graves, Martin J. Patterson, Ilse Slough, Rhys A. Schroyer, Rosemary Fernando, Disala Kumar, Subramanya Lee, Sarah Parker, Geoffrey J.M. Sarov‐Blat, Lea McEniery, Carmel Middlemiss, Jessica Sprecher, Dennis Janiczek, Robert L. Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study |
title | Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study |
title_full | Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study |
title_fullStr | Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study |
title_full_unstemmed | Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study |
title_short | Evaluation of Dynamic Contrast‐Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study |
title_sort | evaluation of dynamic contrast‐enhanced mri measures of lung congestion and endothelial permeability in heart failure: a prospective method validation study |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544235/ https://www.ncbi.nlm.nih.gov/pubmed/35343008 http://dx.doi.org/10.1002/jmri.28174 |
work_keys_str_mv | AT cheriyanjoseph evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT robertsalexandra evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT robertscaleb evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT gravesmartinj evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT pattersonilse evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT sloughrhysa evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT schroyerrosemary evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT fernandodisala evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT kumarsubramanya evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT leesarah evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT parkergeoffreyjm evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT sarovblatlea evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT mcenierycarmel evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT middlemissjessica evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT sprecherdennis evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy AT janiczekrobertl evaluationofdynamiccontrastenhancedmrimeasuresoflungcongestionandendothelialpermeabilityinheartfailureaprospectivemethodvalidationstudy |